scholarly journals INTRODUCTION AND MYTH BUSTERS OF COVID -19

Author(s):  
Prashant Chauhan

COVID-19 also known as SARS-CoV-2 is the virus that attacks the respiratory system of a person. The first case in humans of this virus was reported in Wuhan city, China, in December 2019. It was believed that the virus came from the food market of the China. Also it was linked with the bats. A variety of studies are currently underway or are being carried out to better understand the cause of the outbreak in China , including human case investigations with an onset of symptoms in and around Wuhan in late 2019, Sampling  from markets and farms in areas where the first human cases have been reported and detailed records of the source and type of species of wildlife and agricultural animals sold on these markets. Vaccine have developed by few countries like Russia, United Kingdom, USA, India. But there are no claim of 100% result of it so we have to take all the protective measures to protect us from the COVID-19 and don’t trust the myths that are being spread everywhere out there.

2020 ◽  
Vol 11 (SPL1) ◽  
pp. 1902-1904
Author(s):  
Lavi Arya

COVID-19 sudden outburst is declared as a serious public medical health issue worldwide by WHO, in March 2020. The first case of COVID-19 was seen officially in Wuhan City, China, in December 2019. It’s a pandemic to which all the countries has to take action in the detection of the infection and prevention of it’s spread. Despite global efforts to contain the disease spread, the outbreak is still on the rise because of the community spread pattern of this infection. Earlier the mode of transmission of the virus was seen in animal to person but now the transmission is from person to person through respiratory droplet infection the confirmed case is seen in many countries and are increasing day by day Fever, cough and cold, difficulty in breathing, tiredness can be seen in the patients suffering. The virus is affecting our health, economy, social life. Till the time we don’t have any medication at least we should try to prevent the spread of the virus. The points which can help in the prevention of the spread of the virus in the community are maintaining of hand sanitation, social distancing, Avoiding person to person contact and Quarantine. Increase in a number of testing, detecting COVID-19 positive patients will also help to reduce the spread of virus and secondary cases with strict quarantine rules.


2021 ◽  
Vol 8 (2) ◽  
pp. 01-03
Author(s):  
Ashish Gujrathi

Coronavirus (COVID-19) was recognized in late December in Hubei province of Wuhan city in China. This highly contagious disease, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from humans to humans. After the first case in Wuhan, the disease rapidly spread to other parts of the globe. On March 11, 2020, the World Health Organization (WHO) made an assessment that COVID-19 can be characterized as a pandemic. Thus, social-distancing became an important measure to stop the spread of this disease. Various countries across the world adopted nationwide lockdowns. This led to a completely new scenario for the world, where every business in each industry faced new challenges and witnessed new opportunities. Similarly, the medical personal protective industry, a vital part of the healthcare sector, also witnessed new growth opportunities.


2002 ◽  
Vol 116 (4) ◽  
pp. 304-306 ◽  
Author(s):  
Mitsuhiko Nakahira ◽  
Shuji Matsumoto ◽  
Naoko Mukushita ◽  
Hiroaki Nakatani

The purpose of this study was to report the first case (to our knowlege) of primary laryngeal aspergillosis in a patient with underlying CD4+ T lymphocytopenia. Laryngeal involvement of Aspergillus is more commonly seen as a part of a wider infection involving the respiratory system in an immunocompromised host. However, primary infection of the larynx is extremely rare. Although there were 12 cases of primary laryngeal aspergillosis previously reported in healthy subjects, there is no known study describing immunological findings in detail. We report a case of primary laryngeal aspergillosis in a healthy 79-year-old male. The examination of his immunity subsequently revealed that there was a marked decline in the number of CD4+ T lymphocytes and a decrease in the ratio of CD4+ to CD8+. It is suggested that it is essential to examine the defence mechanisms, specifically cell-mediated immunity in a patient showing primary laryngeal aspergillosis.


2021 ◽  
Vol 55 (1) ◽  
pp. 72-83 ◽  
Author(s):  
Tamiris Cristhina Resende ◽  
Marco Antonio Catussi Paschoalotto ◽  
Stephen Peckham ◽  
Claudia Souza Passador ◽  
João Luiz Passador

Abstract This paper aims to analyse the coordination and cooperation in Primary Health Care (PHC) measures adopted by the British government against the spread of the COVID-19. PHC is clearly part of the solution founded by governments across the world to fight against the spread of the virus. Data analysis was performed based on coordination, cooperation, and PHC literature crossed with documentary analysis of the situation reports released by the World Health Organisation and documents, guides, speeches and action plans on the official UK government website. The measures adopted by the United Kingdom were analysed in four periods, which helps to explain the courses of action during the pandemic: pre-first case (January 22- January 31, 2020), developing prevention measures (February 1 -February 29, 2020), first Action Plan (March 1- March 23, 2020) and lockdown (March 24-May 6, 2020). Despite the lack of consensus in essential matters such as Brexit, the nations in the United Kingdom are working together with a high level of cooperation and coordination in decision-making during the COVID-19 pandemic.


2003 ◽  
Vol 7 (51) ◽  
Author(s):  

The first case of variant Creutzfeldt-Jakob disease (vCJD) thought to have been infected via a blood transfusion may have been seen in the United Kingdom


2020 ◽  
Vol 11 (5) ◽  
pp. 98-102
Author(s):  
Amit Tirth ◽  
Md Nazamuddin Tafadar ◽  
Ravishankar Lingesha Telgi ◽  
Monika Dr

The outbreak of SARS-COV2 responsible COVID-19 disease created a worldwide health emergency. After its first case was accounted for in 2019, 31st December by World Health Organization in Wuhan city of china, and afterward spreading in different nations, with India surpassing cases even the inception nation as on twentieth of May 2020. The WHO declared the disease as pandemic way back and countries over the world adoptinglockdown and contact tracing to limit the contagion. The virus transmits person-to-person predominantlythrough respiratory routes through direct contact, droplets and possibly aerosols. Because of the unique nature of practice in dentistry, most procedure generate significant amount of aerosols and droplets, posing a possible risk of infection transmission. Understanding the concern of risk of transmission in dental practice, this literature is aimed to discuss the possible risk associated with practice and aim to raise awareness of the same with preventive measures especially after the lockdown end in day to day practice.


Author(s):  
Ramesh Verma ◽  
Vinod Chayal ◽  
Meenakshi Kalhan ◽  
Rohit Dhaka ◽  
Ginni Agrawal ◽  
...  

Coronavirus disease is caused by a novel virus belonging to the family of corona viruses similar to severe acute respiratory syndrome (SARS) and  name given to the novel virus as SARS Coronavirus- 2 (SARS-CoV-2) and the disease was named as COVID-19 on 11th February 2020 by World Health Organization (WHO). First case of this infection was reported in December 2019 in Wuhan city of China and after that it spread globally.3 On 30th January 2020, WHO declared this disease as Public Health Emergency of International Concern (PHEIC) and on 11th March 2020, WHO declared it as a pandemic when the infection was reported from all six WHO regions.


Author(s):  
Mradul Kumar Daga ◽  

COVID-19 and its sequelae are primarily known to affect the respiratory system. However, it can have varied manifestations affecting other systems as well. COVID-19 can lead to reactivation of tuberculosis which can have unusual extrapulmonary presentations as well. Coinfection of COVID-19 and tuberculosis is a risk factor for poor outcome. Here, we describe a series of two cases of COVID-19 with tuberculosis. In the first case, a patient who had apparently recovered from COVID-19 presented only a week later with polyserositis, and ultimately was diagnosed to be a case of disseminated tuberculosis. In the second case, the patient presented with COVID-19 and TB together. Clinicians must be aware and vigilant for this coinfection and complication in COVID-19 recovered patients even if they were of mild/ asymptomatic category.


2020 ◽  
Author(s):  
Jürgen Margraf ◽  
Julia Brailovskaia ◽  
Silvia Schneider

Introduction: In the absence of vaccines or causal therapies, behavioral measures such as wearing face masks and keeping distance are central to fighting Covid-19. Yet, their benefits are often questioned and adherence is variable. Methods: We examined in representative samples across eight countries (N = 7,568) whether adherence reported around June 1, 2020 predicted the increase in Covid-19 mortality by August 31, 2020. Results: Mortality increased 81.3% in low adherence countries (United States, Sweden, Poland, Russia), 8.4% in high adherence countries (Germany, France, Spain, United Kingdom). Across countries adherence and subsequent mortality increases correlated with r = -0.91. Limitations: No African or South American countries were included in the present study, which limits the generalizability of the findings.Conclusions: While reported Covid-19 mortality is likely to be influenced by other factors, the almost tenfold difference in additional mortality is significant, and may inform decisions when choosing whether to prioritize individual liberty rights or health-protective measures.


Author(s):  
Hoang Pham

COVID-19 is caused by a coronavirus called SARS-CoV-2. Many countries around the world implemented their own policies and restrictions designed to limit the spread of Covid-19 in recent months. Businesses and schools transitioned into working and learning remotely. In the United States, many states were under strict orders to stay home at least in the month of April. In recent weeks, there are some significant changes related restrictions include social-distancing, reopening states, and staying-at-home orders. The United States surpassed 2 million coronavirus cases on Monday, June 15, 2020 less than five months after the first case was confirmed in the country. The virus has killed at least 115,000 people in the United States as of Monday, June 15, 2020, according to data from Johns Hopkins University. With the recent easing of coronavirus-related restrictions and changes on business and social activity such as stay-at-home, social distancing since late May 2020 hoping to restore economic and business activities, new Covid-19 outbreaks are on the rise in many states across the country. Some researchers expressed concern that the process of easing restrictions and relaxing stay-at-home orders too soon could quickly surge the number of infected Covid-19 cases as well as the death toll in the United States. Some of these increases, however, could be due to more testing sites in the communities while others may be are the results of easing restrictions due to recent reopening and changed policies, though the number of daily death toll does not appear to be going down in recent days due to Covid-19 in the U.S. This raises the challenging question: • How can policy decision-makers and community leaders make the decision to implement public policies and restrictions and keep or lift staying-at-home orders of ongoing Covid-19 pandemic for their communities in a scientific way? In this study, we aim to develop models addressing the effects of recent Covid-19 related changes in the communities such as reopening states, practicing social-distancing, and staying-at-home orders. Our models account for the fact that changes to these policies which can lead to a surge of coronavirus cases and deaths, especially in the United States. Specifically, in this paper we develop a novel generalized mathematical model and several explicit models considering the effects of recent reopening states, staying-at-home orders and social-distancing practice of different communities along with a set of selected indicators such as the total number of coronavirus recovered and new cases that can estimate the daily death toll and total number of deaths in the United States related to Covid-19 virus. We compare the modeling results among the developed models based on several existing criteria. The model also can be used to predict the number of death toll in Italy and the United Kingdom (UK). The results show very encouraging predictability for the proposed models in this study. The model predicts that 128,500 to 140,100 people in the United States will have died of Covid-19 by July 4, 2020. The model also predicts that between 137,900 and 154,000 people will have died of Covid-19 by July 31, and 148,500 to 169,700 will have died by the end of August 2020, as a result of the SARS-CoV-2 coronavirus that causes COVID-19 based on the Covid-19 death data available on June 13, 2020. The model also predicts that 34,900 to 37,200 people in Italy will have died of Covid-19 by July 4, and 36,900 to 40,400 people will have died by the end of August based on the data available on June 13, 2020. The model also predicts that between 43,500 and 46,700 people in the United Kingdom will have died of Covid-19 by July 4, and 48,700 to 51,900 people will have died by the end of August, as a result of the SARS-CoV-2 coronavirus that causes COVID-19 based on the data available on June 13, 2020. The model can serve as a framework to help policy makers a scientific approach in quantifying decision-makings related to Covid-19 affairs.


Sign in / Sign up

Export Citation Format

Share Document